Euromonitor: RRP Market Reaches $74 Billion, Accounting for 12.7% of Global Nicotine Industry as Five Key Trends Drive Transformation

Sep.29.2025
Euromonitor: RRP Market Reaches $74 Billion, Accounting for 12.7% of Global Nicotine Industry as Five Key Trends Drive Transformation
In 2025, global tobacco leaf production surged, but prices stagnated as climate change intensified farming risks. 2Firsts reports from the ITGA meeting, revealing structural challenges and transition pressures in the industry.

Key Points

 

  • Despite regulations and competition, the global nicotine market remained strong in 2024, with 3.5 trillion legal units consumed worldwide (excluding China) and a total value of about $582 billion.

 

  • Cigarette use is slowly declining, while vaping, nicotine pouches and heated tobacco products are growing, with RRP users increasing by 8.7% during the review period.

 

  • By 2029, nicotine pouches are projected to account for 10% to 15% of total equivalent nicotine consumption in the U.S. market.

 

  • Major trends include reduced public visibility of nicotine use; market polarization; greater adoption of alternative nicotine formats; intensifying regulatory pressures; growth of illicit trade in tightly regulated markets; and expansion beyond nicotine, including herbal, cannabinoid and synthetic stimulant products.

 

  • Economic factors are encouraging multiple product use and price-sensitive choices, while interest in functional benefits (stress relief, cognitive enhancement) is growing.

 

  • The industry is expected to stay adaptive and innovative, balancing regulation and competition while exploring new delivery methods and product categories to maintain consumer appeal.

 


 

A group of people sitting at tables in front of a projection screen

AI-generated content may be incorrect.
Euromonitor’s Shane MacGuill highlighted key trends in the global nicotine business during ITGA’s annual meeting in Dortmund. | Photo: Taco Tuinstra

 

2Firsts, September 29, 2025 (By Taco Tuinstra) — Despite numerous regulatory and competitive challenges, the global nicotine business remains remarkably resilient, according to Euromonitor International. In a presentation during the International Tobacco Growers Association’s annual general meeting on Sept. 19 in Dortmund, Germany, Shane MacGuill, Euromonitor’s global lead for tobacco and cannabis, highlighted key trends and examined the outlook for both combustible cigarettes and next-generation products.

 

State of the Industry

 

Total worldwide legal nicotine consumption, excluding China, reached 3.5 trillion units in 2024, with cigarettes dominating at 2.7 trillion sticks but steadily declining. Notably, reduced risk products (RRPs) such as vaping devices, nicotine pouches and heated tobacco products have been gaining ground, though cigarettes retain a dominant share at more than three out of four legal nicotine units. The industry’s overall value stood at $508 billion for cigarettes and $74 billion for RRPs in 2024. While the number of smokers decreased by 1.6 percent during the review period, the number RRP population jumped by 8.7 percent, according to Euromonitor. Going forward, the market intelligence company expects cigarette volumes to continue shrinking as RRPs gain prominence.

 

Five Trends Shaping Nicotine

 

In his presentation, MacGuill identified five trends in the global nicotine business:

 

1. Declining prevalence and visibility: Smoking rates are dropping globally, and visibility of nicotine use is diminishing due to tighter regulations and shifting societal norms. Measures such as Milan’s ban on outdoor smoking illustrate this shift, pushing consumption out of public view and reinforcing negative perceptions of smoking.

 

2. Consumption polarization: Value disparities are widening within nicotine categories. Economy brands are capturing substantial market share as price remains a top concern for consumers, fueling a move towards poly-usage and “downtrading,” especially during economic uncertainty.

 

3. Alternative consumption methods: The landscape is expanding with more consumers adopting alternative nicotine products. Innovations in flavors and delivery forms drive this shift, especially in markets like the U.S., where nicotine pouches could constitute between 10% and 15% of all equivalent volume by 2029.

 

4. Regulatory pressures: Legislation continues to shape the industry, with future regulation likely to address product characteristics, sustainability and compliance. Enforcement is increasingly critical, as law-abiding face fierce competition from illicit operators. In Australia, which has the world’s most expensive cigarettes and one of its strictest regulatory frameworks, illegal tobacco products now account for an outsized share of the market, according to MacGuill.

 

5. Beyond nicotine: Demand for function-driven products and novel stimulants is rising. Major companies are exploring herbal remedies, cannabinoid-infused products and synthetic analogues, reflecting consumer interest in stress relief, cognitive enhancement and tailored health solutions. In the United States, cannabis use will soon be more likely among consumers than cigarette smoking, MacGuill noted.

 

Future Outlook

 

Nicotine’s appeal is being reimagined functionally, with a focus on delivery, flavor and consumer needs. Regulatory, competitive and consumer forces will continue to diverge, while economic factors encourage downtrading and multiple product usage, according to Euromonitor. Although “endgame” measures for tobacco control remain a topic of debate, overall market resilience and innovation suggest a nuanced, adaptive future for global nicotine consumption.

 

Cover Image is generated by ChatGPT

GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
Germany's Magdeburg Main Customs Office seized 115,800 untaxed e-cigarettes containing a combined 4.366 million mL of e-liquid during four truck inspections between August 10 and September 4, 2026. The seizures prevented an estimated €1.397 million in tax losses and set a record for the customs office's jurisdiction. Criminal proceedings have been initiated against four truck drivers. The case follows a separate German investigation involving more than 7.6 million illicit vapes and an estimated €33.3 million in excise-tax losses.
Enforcement
Oct.13
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Swedish nicotine pouch brand Kelly White is building its strategy around adult female consumers. Founder and CEO Sophia Wilsby told 2Firsts that women accounted for around 70% of the brand’s repeat customers on HAYPP in Sweden in 2025. The interview explores female consumer segmentation, product and design differentiation, gender stereotypes, packaging regulation, and how independent brands can compete with global players such as ZYN and VELO while considering funding, partnerships and future ownership options.
Business
Sep.24
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
South Korea Constitutional Court Upholds Volume-Based E-Liquid Tax, With Challenged Rates at KRW 370 and KRW 628 per Milliliter
South Korea Constitutional Court Upholds Volume-Based E-Liquid Tax, With Challenged Rates at KRW 370 and KRW 628 per Milliliter
South Korea's Constitutional Court has upheld fixed taxes on nicotine-containing e-cigarette liquids based on solution volume, ruling that challenged provisions imposing KRW 370 per milliliter in individual consumption tax and KRW 628 per milliliter in tobacco consumption tax do not violate the Constitution. The cases stemmed from historical disputes involving importers that reported nicotine as being extracted from tobacco stems rather than leaves. South Korea has since broadened its tobacco definition to include synthetic nicotine, while current tax laws provide reduced rates for certain products not derived from tobacco.
Sep.18
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16